The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions

Kidney International, Supplement

Volumn 64, Issue 88, 2003, Pages

  Ter Wee, P M ^a   Beelen, R H J ^a   Van Den Born, J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bicarbonate; Glucose degradation product; Peritoneal dialysis

Indexed keywords

BUFFER; DIALYSIS FLUID; BICARBONATE;

ACIDITY; ANGIOGENESIS; ELECTRON MICROSCOPY; EXCIPIENT COMPATIBILITY; EXPERIMENTAL DIABETES MELLITUS; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HOST RESISTANCE; INDWELLING CATHETER; LONG TERM EXPOSURE; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PH MEASUREMENT; PRIORITY JOURNAL; RAT STRAIN; REVIEW; SPECIES COMPARISON; TISSUE INJURY; TISSUE SECTION; ANIMAL; ANIMAL MODEL; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; MATERIALS TESTING; PATHOLOGY; PERITONEUM; STANDARD;

ANIMALS; BICARBONATES; BUFFERS; DIALYSIS SOLUTIONS; MATERIALS TESTING; MODELS, ANIMAL; PERITONEAL DIALYSIS; PERITONEUM;

EID: 0345305347     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.08808.x     Document Type: Review

References (40)

1. DI PAOLO N, SACCHI G, DE MIA M, et al: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 44:204-211, 1986
2. DOBBIE JW: Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis. Perit Dial Int 13(Suppl 2):S585-587. 1993
3. HONDA K, NITTA K, HORITA S, et al: Morphological changes in the peritoneal vasulature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
4. WILLIAMS JD, CRAIG KJ, TOPLEY N, THE PERITONEAL BIOPSY STUDY GROUP: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
5. CATALAN MP, REYERO A, EGIDO J, ORTIZ A: Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 12:2442-2449, 2001
6. HA H, YU MR, CHOI HN, et al: Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int 20(Suppl 5):S10-S18, 2000
7. BRULEZ HF, HEEZIUS EC, DE FIJTER CW, et al: In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. Adv Perit Dial 10:241-244, 1994
8. JORRES A, GAHL GM, LUDAT K, et al: In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis. Nephrol Dial Transplant 12:543-549, 1997
9. HA H, CHA MK, CHOI HN, LEE HB: Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177, 2002
10. BRULEZ HF, TER WEE PM, SNIJDERS SV, et al: Mononuclear leucocyte function tests in the assessment of the biocompatibility of peritoneal dialysis fluids. J Clin Pathol 52:901-909, 1999
11. PLUM J, SCHOENICKE G, GRABENSEE B: Osmotic agents and buffers in peritoneal dialysis solution: Monocyte cytokine release and in vitro cytotoxicity. Am J Kidney Dis 30:413-422, 1997
12. FOUGERAY S, SLINGENEYER A, BASTIDE JM, et al: Dialysis solutions buffered with lactate or bicarbonate: In vitro comparison of two dialysis solutions on human peritoneal cell growth from ESRD and non-ESRD patients. Adv Perit Dial 10:235-240, 1994
13. SCHALKWIJK CG, POSTHUMA N, TEN BRINK HJ, et al: Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 19:325-333, 1999
14. LAMEIRE N, VAN BIESEN W, VAN LANDSCHOOT M, et al: Experimental models in peritoneal dialysis: A European experience. Kidney Int 54:2194-2206, 1998
15. GOTLOIB L, CRASSWELLER P, RODELLA H, et al: Experimental model for studies of continuous peritoneal dialysis in uremic rabbits. Nephron 31:254-259, 1982
16. HEKKING LH, AALDERS MC, VAN GELDEROP E, et al: Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis. Adv Perit Dial 14:14-18, 1998
17. HEKKING LH, ZAREIE M, DRIESPRONG BA, et al: Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12:2775-2786, 2001
18. KREDIET RT, ZWEERS MM, VAN DER WAL AC, STRUIJK DG: Neoangiogenesis in the peritoneal membrane. Perit Dial Int 20(Suppl 2):S19-S25, 2000
19. MARGETTS PJ, KOLB M, YU L, et al: Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 160:2285-2294, 2002
20. ZAREIE M, VAN LAMBALGEN AA, DE VRIESE AS, et al: Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis. Perit Dial Int 22:655-662, 2002
21. MARGETTS PJ, GYORFFY S, KOLB M, et al: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728, 2002
22. WIECZOROWSKA-TOBIS K, BRELINSKA R, BREBOROWICZ A, OREOPOULOS DG: Morphologic aspects of chronic peritoneal dialysis in a rat model. Perit Dial Int 21(Suppl 3):S342-S344, 2001
23. ZAREIE M, HEKKING LHP, WELTEN AGA, et al: Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant 2003 (In press)
24. NILSSON BO: Biological effects of aminoguanidine: An update. Inflamm Res 48:509-515, 1999
25. LEE EA, OH JH, LEE HA, et al: Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine. Perit Dial Int 21:245-253, 2001
26. MORTIER S, DE VRIESE AS. VAN DE VOORDE J, et al: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 13:480-489, 2002
27. YATZIDIS H: Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution. Pent Dial Int 13:302-306, 1993
28. MUSI B, CARLSSON O, RIPPE A, et al: Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit Dial Int 18:303-310, 1998
29. ZHENG Z-H, SEDERHOLM F, ANDERSTAM B, et al: Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats. Kidney Int 60:2392-2398, 2001
30. MORTIER S, DE VRIESE AS, MCLOUGHLIN RM, et al: Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 14:1296-1306, 2003
31. GOTLOIB L, WAJSBROT V, SHOSTAK A, KUSHNIER R: Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid. Nephron 73:219-227, 1996
32. PARK MS, KIM JK, HOLMES C, WEISS MF: Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation. Perit Dial Int 20(Suppl 5):S33-S38, 2000
33. SUZUKI K, KHANNA R, NOLPH KD, et al: Effects of bicarbonate dialysis solution on peritoneal transport in rats. Adv Perit Dial 12:24-26, 1996
34. PAWLACZYK K, KUZLAN-PAWLACZYK M, WIECZOROWSKA-TOBIS K, et al: Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defence in rats. Perit Dial Int 19(Suppl 2):S370-377, 1998
35. DI PAOLO N. GAROSI G, PETRINI G, MONACI G: Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit. Nephron 74:594-599, 1996
36. SCHAMBYE HT, FLESNER P, PEDERSEN RB, et al: Bicarbonate versus lactate-based CAPD fluids: A biocompatibility study in rabbits. Pent Dial Int 12:281-286
37. WIECZOROWSKA-TOBIS K, KORYBALSKA K, POLUBINSKA A, et al: Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats. Adv Perit Dial 13:42-46, 1997
38. JONES S, HOLMES CJ, KREDIET RT, et al: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59:1529-1538, 2001
39. RIPPE B, SIMONSEN O, HEIMBURGER O, et al: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59:348-357, 2001
40. TRANAEUS A: A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution - Clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 20:516-523, 2000